Request for Covid-19 Impact Assessment of this Report
The United States Diagnostic Radioisotopes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Diagnostic Radioisotopes market, reaching US$ million by the year 2028. As for the Europe Diagnostic Radioisotopes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Diagnostic Radioisotopes players cover Bracco Imaging, Bayer, Curium Pharmaceuticals, and Nordion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radioisotopes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Radioisotopes Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Diagnostic Radioisotopes by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Diagnostic Radioisotopes by Country/Region, 2017, 2022 & 2028
2.2 Diagnostic Radioisotopes Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Radioisotopes Sales by Type
2.3.1 Global Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
2.3.2 Global Diagnostic Radioisotopes Revenue and Market Share by Type (2017-2022)
2.3.3 Global Diagnostic Radioisotopes Sale Price by Type (2017-2022)
2.4 Diagnostic Radioisotopes Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radioisotopes Sales by Application
2.5.1 Global Diagnostic Radioisotopes Sale Market Share by Application (2017-2022)
2.5.2 Global Diagnostic Radioisotopes Revenue and Market Share by Application (2017-2022)
2.5.3 Global Diagnostic Radioisotopes Sale Price by Application (2017-2022)
3 Global Diagnostic Radioisotopes by Company
3.1 Global Diagnostic Radioisotopes Breakdown Data by Company
3.1.1 Global Diagnostic Radioisotopes Annual Sales by Company (2020-2022)
3.1.2 Global Diagnostic Radioisotopes Sales Market Share by Company (2020-2022)
3.2 Global Diagnostic Radioisotopes Annual Revenue by Company (2020-2022)
3.2.1 Global Diagnostic Radioisotopes Revenue by Company (2020-2022)
3.2.2 Global Diagnostic Radioisotopes Revenue Market Share by Company (2020-2022)
3.3 Global Diagnostic Radioisotopes Sale Price by Company
3.4 Key Manufacturers Diagnostic Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radioisotopes Product Location Distribution
3.4.2 Players Diagnostic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Diagnostic Radioisotopes by Geographic Region
4.1 World Historic Diagnostic Radioisotopes Market Size by Geographic Region (2017-2022)
4.1.1 Global Diagnostic Radioisotopes Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Diagnostic Radioisotopes Annual Revenue by Geographic Region
4.2 World Historic Diagnostic Radioisotopes Market Size by Country/Region (2017-2022)
4.2.1 Global Diagnostic Radioisotopes Annual Sales by Country/Region (2017-2022)
4.2.2 Global Diagnostic Radioisotopes Annual Revenue by Country/Region
4.3 Americas Diagnostic Radioisotopes Sales Growth
4.4 APAC Diagnostic Radioisotopes Sales Growth
4.5 Europe Diagnostic Radioisotopes Sales Growth
4.6 Middle East & Africa Diagnostic Radioisotopes Sales Growth
5 Americas
5.1 Americas Diagnostic Radioisotopes Sales by Country
5.1.1 Americas Diagnostic Radioisotopes Sales by Country (2017-2022)
5.1.2 Americas Diagnostic Radioisotopes Revenue by Country (2017-2022)
5.2 Americas Diagnostic Radioisotopes Sales by Type
5.3 Americas Diagnostic Radioisotopes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radioisotopes Sales by Region
6.1.1 APAC Diagnostic Radioisotopes Sales by Region (2017-2022)
6.1.2 APAC Diagnostic Radioisotopes Revenue by Region (2017-2022)
6.2 APAC Diagnostic Radioisotopes Sales by Type
6.3 APAC Diagnostic Radioisotopes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Diagnostic Radioisotopes by Country
7.1.1 Europe Diagnostic Radioisotopes Sales by Country (2017-2022)
7.1.2 Europe Diagnostic Radioisotopes Revenue by Country (2017-2022)
7.2 Europe Diagnostic Radioisotopes Sales by Type
7.3 Europe Diagnostic Radioisotopes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Radioisotopes by Country
8.1.1 Middle East & Africa Diagnostic Radioisotopes Sales by Country (2017-2022)
8.1.2 Middle East & Africa Diagnostic Radioisotopes Revenue by Country (2017-2022)
8.2 Middle East & Africa Diagnostic Radioisotopes Sales by Type
8.3 Middle East & Africa Diagnostic Radioisotopes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radioisotopes
10.3 Manufacturing Process Analysis of Diagnostic Radioisotopes
10.4 Industry Chain Structure of Diagnostic Radioisotopes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radioisotopes Distributors
11.3 Diagnostic Radioisotopes Customer
12 World Forecast Review for Diagnostic Radioisotopes by Geographic Region
12.1 Global Diagnostic Radioisotopes Market Size Forecast by Region
12.1.1 Global Diagnostic Radioisotopes Forecast by Region (2023-2028)
12.1.2 Global Diagnostic Radioisotopes Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Diagnostic Radioisotopes Forecast by Type
12.7 Global Diagnostic Radioisotopes Forecast by Application
13 Key Players Analysis
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Diagnostic Radioisotopes Product Offered
13.1.3 Bracco Imaging Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Diagnostic Radioisotopes Product Offered
13.2.3 Bayer Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Curium Pharmaceuticals
13.3.1 Curium Pharmaceuticals Company Information
13.3.2 Curium Pharmaceuticals Diagnostic Radioisotopes Product Offered
13.3.3 Curium Pharmaceuticals Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Curium Pharmaceuticals Main Business Overview
13.3.5 Curium Pharmaceuticals Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Diagnostic Radioisotopes Product Offered
13.4.3 Nordion Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Diagnostic Radioisotopes Product Offered
13.5.3 Triad Isotopes Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Diagnostic Radioisotopes Product Offered
13.6.3 Lantheus Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 GE Healthcare
13.7.1 GE Healthcare Company Information
13.7.2 GE Healthcare Diagnostic Radioisotopes Product Offered
13.7.3 GE Healthcare Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GE Healthcare Main Business Overview
13.7.5 GE Healthcare Latest Developments
13.8 China Isotope & Radiation
13.8.1 China Isotope & Radiation Company Information
13.8.2 China Isotope & Radiation Diagnostic Radioisotopes Product Offered
13.8.3 China Isotope & Radiation Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 China Isotope & Radiation Main Business Overview
13.8.5 China Isotope & Radiation Latest Developments
13.9 Jubilant Pharma
13.9.1 Jubilant Pharma Company Information
13.9.2 Jubilant Pharma Diagnostic Radioisotopes Product Offered
13.9.3 Jubilant Pharma Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jubilant Pharma Main Business Overview
13.9.5 Jubilant Pharma Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Diagnostic Radioisotopes Product Offered
13.10.3 Eli Lilly Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Diagnostic Radioisotopes Product Offered
13.11.3 Novartis Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 SIEMENS
13.12.1 SIEMENS Company Information
13.12.2 SIEMENS Diagnostic Radioisotopes Product Offered
13.12.3 SIEMENS Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SIEMENS Main Business Overview
13.12.5 SIEMENS Latest Developments
13.13 Dongcheng
13.13.1 Dongcheng Company Information
13.13.2 Dongcheng Diagnostic Radioisotopes Product Offered
13.13.3 Dongcheng Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dongcheng Main Business Overview
13.13.5 Dongcheng Latest Developments
13.14 Navidea
13.14.1 Navidea Company Information
13.14.2 Navidea Diagnostic Radioisotopes Product Offered
13.14.3 Navidea Diagnostic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Navidea Main Business Overview
13.14.5 Navidea Latest Developments
14 Research Findings and Conclusion
Table 1. Diagnostic Radioisotopes Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Diagnostic Radioisotopes Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of F-18
Table 5. Major Players of Other
Table 6. Global Diagnostic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 7. Global Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
Table 8. Global Diagnostic Radioisotopes Revenue by Type (2017-2022) & ($ million)
Table 9. Global Diagnostic Radioisotopes Revenue Market Share by Type (2017-2022)
Table 10. Global Diagnostic Radioisotopes Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Diagnostic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 12. Global Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Table 13. Global Diagnostic Radioisotopes Revenue by Application (2017-2022)
Table 14. Global Diagnostic Radioisotopes Revenue Market Share by Application (2017-2022)
Table 15. Global Diagnostic Radioisotopes Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Diagnostic Radioisotopes Sales by Company (2020-2022) & (K Units)
Table 17. Global Diagnostic Radioisotopes Sales Market Share by Company (2020-2022)
Table 18. Global Diagnostic Radioisotopes Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Diagnostic Radioisotopes Revenue Market Share by Company (2020-2022)
Table 20. Global Diagnostic Radioisotopes Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Diagnostic Radioisotopes Producing Area Distribution and Sales Area
Table 22. Players Diagnostic Radioisotopes Products Offered
Table 23. Diagnostic Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Diagnostic Radioisotopes Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Diagnostic Radioisotopes Sales Market Share Geographic Region (2017-2022)
Table 28. Global Diagnostic Radioisotopes Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Diagnostic Radioisotopes Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Diagnostic Radioisotopes Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Diagnostic Radioisotopes Sales Market Share by Country/Region (2017-2022)
Table 32. Global Diagnostic Radioisotopes Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Diagnostic Radioisotopes Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Diagnostic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 35. Americas Diagnostic Radioisotopes Sales Market Share by Country (2017-2022)
Table 36. Americas Diagnostic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Diagnostic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 38. Americas Diagnostic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 39. Americas Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
Table 40. Americas Diagnostic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 41. Americas Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Table 42. APAC Diagnostic Radioisotopes Sales by Region (2017-2022) & (K Units)
Table 43. APAC Diagnostic Radioisotopes Sales Market Share by Region (2017-2022)
Table 44. APAC Diagnostic Radioisotopes Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Diagnostic Radioisotopes Revenue Market Share by Region (2017-2022)
Table 46. APAC Diagnostic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 47. APAC Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
Table 48. APAC Diagnostic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 49. APAC Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Table 50. Europe Diagnostic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 51. Europe Diagnostic Radioisotopes Sales Market Share by Country (2017-2022)
Table 52. Europe Diagnostic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Diagnostic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 54. Europe Diagnostic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 55. Europe Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
Table 56. Europe Diagnostic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 57. Europe Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Diagnostic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Diagnostic Radioisotopes Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Diagnostic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Diagnostic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Diagnostic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Diagnostic Radioisotopes Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Diagnostic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Diagnostic Radioisotopes
Table 67. Key Market Challenges & Risks of Diagnostic Radioisotopes
Table 68. Key Industry Trends of Diagnostic Radioisotopes
Table 69. Diagnostic Radioisotopes Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Diagnostic Radioisotopes Distributors List
Table 72. Diagnostic Radioisotopes Customer List
Table 73. Global Diagnostic Radioisotopes Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Diagnostic Radioisotopes Sales Market Forecast by Region
Table 75. Global Diagnostic Radioisotopes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Diagnostic Radioisotopes Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Diagnostic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Diagnostic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Diagnostic Radioisotopes Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Diagnostic Radioisotopes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Diagnostic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Diagnostic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Diagnostic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Diagnostic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Diagnostic Radioisotopes Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Diagnostic Radioisotopes Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Diagnostic Radioisotopes Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Diagnostic Radioisotopes Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Diagnostic Radioisotopes Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Diagnostic Radioisotopes Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Diagnostic Radioisotopes Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Diagnostic Radioisotopes Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bracco Imaging Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 94. Bracco Imaging Diagnostic Radioisotopes Product Offered
Table 95. Bracco Imaging Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Bracco Imaging Main Business
Table 97. Bracco Imaging Latest Developments
Table 98. Bayer Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer Diagnostic Radioisotopes Product Offered
Table 100. Bayer Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Bayer Main Business
Table 102. Bayer Latest Developments
Table 103. Curium Pharmaceuticals Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 104. Curium Pharmaceuticals Diagnostic Radioisotopes Product Offered
Table 105. Curium Pharmaceuticals Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Curium Pharmaceuticals Main Business
Table 107. Curium Pharmaceuticals Latest Developments
Table 108. Nordion Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 109. Nordion Diagnostic Radioisotopes Product Offered
Table 110. Nordion Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Nordion Main Business
Table 112. Nordion Latest Developments
Table 113. Triad Isotopes Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 114. Triad Isotopes Diagnostic Radioisotopes Product Offered
Table 115. Triad Isotopes Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Triad Isotopes Main Business
Table 117. Triad Isotopes Latest Developments
Table 118. Lantheus Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 119. Lantheus Diagnostic Radioisotopes Product Offered
Table 120. Lantheus Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Lantheus Main Business
Table 122. Lantheus Latest Developments
Table 123. GE Healthcare Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 124. GE Healthcare Diagnostic Radioisotopes Product Offered
Table 125. GE Healthcare Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. GE Healthcare Main Business
Table 127. GE Healthcare Latest Developments
Table 128. China Isotope & Radiation Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 129. China Isotope & Radiation Diagnostic Radioisotopes Product Offered
Table 130. China Isotope & Radiation Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. China Isotope & Radiation Main Business
Table 132. China Isotope & Radiation Latest Developments
Table 133. Jubilant Pharma Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 134. Jubilant Pharma Diagnostic Radioisotopes Product Offered
Table 135. Jubilant Pharma Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Jubilant Pharma Main Business
Table 137. Jubilant Pharma Latest Developments
Table 138. Eli Lilly Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 139. Eli Lilly Diagnostic Radioisotopes Product Offered
Table 140. Eli Lilly Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Eli Lilly Main Business
Table 142. Eli Lilly Latest Developments
Table 143. Novartis Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 144. Novartis Diagnostic Radioisotopes Product Offered
Table 145. Novartis Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 146. Novartis Main Business
Table 147. Novartis Latest Developments
Table 148. SIEMENS Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 149. SIEMENS Diagnostic Radioisotopes Product Offered
Table 150. SIEMENS Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 151. SIEMENS Main Business
Table 152. SIEMENS Latest Developments
Table 153. Dongcheng Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 154. Dongcheng Diagnostic Radioisotopes Product Offered
Table 155. Dongcheng Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 156. Dongcheng Main Business
Table 157. Dongcheng Latest Developments
Table 158. Navidea Basic Information, Diagnostic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 159. Navidea Diagnostic Radioisotopes Product Offered
Table 160. Navidea Diagnostic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 161. Navidea Main Business
Table 162. Navidea Latest Developments
List of Figures
Figure 1. Picture of Diagnostic Radioisotopes
Figure 2. Diagnostic Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radioisotopes Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Diagnostic Radioisotopes Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Diagnostic Radioisotopes Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tc-99m
Figure 10. Product Picture of F-18
Figure 11. Product Picture of Other
Figure 12. Global Diagnostic Radioisotopes Sales Market Share by Type in 2021
Figure 13. Global Diagnostic Radioisotopes Revenue Market Share by Type (2017-2022)
Figure 14. Diagnostic Radioisotopes Consumed in Oncology
Figure 15. Global Diagnostic Radioisotopes Market: Oncology (2017-2022) & (K Units)
Figure 16. Diagnostic Radioisotopes Consumed in Cardiology
Figure 17. Global Diagnostic Radioisotopes Market: Cardiology (2017-2022) & (K Units)
Figure 18. Diagnostic Radioisotopes Consumed in Other
Figure 19. Global Diagnostic Radioisotopes Market: Other (2017-2022) & (K Units)
Figure 20. Global Diagnostic Radioisotopes Sales Market Share by Application (2017-2022)
Figure 21. Global Diagnostic Radioisotopes Revenue Market Share by Application in 2021
Figure 22. Diagnostic Radioisotopes Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Diagnostic Radioisotopes Revenue Market Share by Company in 2021
Figure 24. Global Diagnostic Radioisotopes Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Diagnostic Radioisotopes Revenue Market Share by Geographic Region in 2021
Figure 26. Global Diagnostic Radioisotopes Sales Market Share by Region (2017-2022)
Figure 27. Global Diagnostic Radioisotopes Revenue Market Share by Country/Region in 2021
Figure 28. Americas Diagnostic Radioisotopes Sales 2017-2022 (K Units)
Figure 29. Americas Diagnostic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 30. APAC Diagnostic Radioisotopes Sales 2017-2022 (K Units)
Figure 31. APAC Diagnostic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 32. Europe Diagnostic Radioisotopes Sales 2017-2022 (K Units)
Figure 33. Europe Diagnostic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Diagnostic Radioisotopes Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Diagnostic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 36. Americas Diagnostic Radioisotopes Sales Market Share by Country in 2021
Figure 37. Americas Diagnostic Radioisotopes Revenue Market Share by Country in 2021
Figure 38. United States Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Diagnostic Radioisotopes Sales Market Share by Region in 2021
Figure 43. APAC Diagnostic Radioisotopes Revenue Market Share by Regions in 2021
Figure 44. China Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Diagnostic Radioisotopes Sales Market Share by Country in 2021
Figure 51. Europe Diagnostic Radioisotopes Revenue Market Share by Country in 2021
Figure 52. Germany Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Diagnostic Radioisotopes Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Diagnostic Radioisotopes Revenue Market Share by Country in 2021
Figure 59. Egypt Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Diagnostic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Diagnostic Radioisotopes in 2021
Figure 65. Manufacturing Process Analysis of Diagnostic Radioisotopes
Figure 66. Industry Chain Structure of Diagnostic Radioisotopes
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...